Successful treatment of refractory anti-signal recognition particle myopathy using abatacept

被引：17
|
作者：
Maeshima, Keisuke [1 ]
Kiyonaga, Yasuhiro [1 ]
Imada, Chiharu [1 ]
Iwakura, Mikako [1 ]
Hamasaki, Hajime [1 ]
Haranaka, Miwa [1 ]
Ishii, Koji [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Immunol & Rheumatol, Oita 8795593, Japan
来源：
RHEUMATOLOGY | 2014年 / 53卷 / 02期
关键词：
ANTIBODIES; RITUXIMAB; ARTHRITIS;
D O I：
10.1093/rheumatology/ket251
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [31] Myopathy associated with anti-signal recognition particle antibodies; diagnosis and management in Egyptian patients: Case report
    El Sherif, R.
    Nishino, I.
    Uruha, A.
    Suzuki, S.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S144 - S144
  • [32] Severe necrotising myopathy and cardiomyopathy with anti-signal recognition peptide antibodies
    Matthews, E.
    Parton, M.
    Humbel, R. L.
    Elliot, P.
    Parry, C.
    Holton, J.
    Hanna, M. G.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 771 - 772
  • [33] Anti-Signal Recognition Particle Autoantibody ELISA Development and Validation: Utility in Patients with Necrotizing Myopathy.
    Aggarwal, Rohit
    Oddis, Chester V.
    Goudeau, Danielle
    Stephans, Chad
    Fertig, Noreen
    Qi Zengbiao
    Koontz, Diane
    Levesque, Marc C.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S827 - S827
  • [34] Correlation of Anti-Signal Recognition Particle Autoantibody Levels With Creatine Kinase Activity in Patients With Necrotizing Myopathy
    Benveniste, Olivier
    Drouot, Laurent
    Jouen, Fabienne
    Charuel, Jean-Luc
    Bloch-Queyrat, Coralie
    Behin, Anthony
    Amoura, Zahir
    Marie, Isabelle
    Guiguet, Marguerite
    Eymard, Bruno
    Gilbert, Daniele
    Tron, Francois
    Herson, Serge
    Musset, Lucile
    Boyer, Olivier
    ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1961 - 1971
  • [35] Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report
    Belkhribchia, Mohamed Reda
    Lobrinus, Johannes Alexander
    Semlil, Lamyaa
    Chauveau, Nicolas
    Ajrinija, Abdelaziz
    Egervari, Kristof
    Ennhaili, Zine Elabidine
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2024, 12
  • [36] Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab
    Wen, Chunbei
    Yang, Jie
    Wei, Dongsheng
    Xu, Changyou
    Yu, Ping
    Luo, Lijun
    RHEUMATOLOGY, 2024, 63 (02)
  • [37] Marked Efficacy of a Therapeutic Strategy in a Patient With Necrotizing Myopathy Associated With Anti-signal Recognition Particle (SRP) Autoantibodies
    Almaghrabi, Murouj
    Almatrafi, Shahad B.
    Alzahrani, Asma
    Alharbi, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [38] Rituximab for patients with myopathy associated with anti-signal recognition particle antibodies: comment on the article by Valiyil et al
    Deligny, Christophe
    Goeb, Vincent
    Dueymes, Maryvonne
    Kahn, Valentine
    Dehlinger, Veronique
    Baptiste, Georges Jean
    Amarof, Khadija
    Arfi, Serge
    ARTHRITIS CARE & RESEARCH, 2011, 63 (03) : 460 - 460
  • [39] Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies
    Ge, Yongpeng
    Yang, Hanbo
    Xiao, Xinyue
    Liang, Lin
    Lu, Xin
    Wang, Guochun
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [40] Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies
    Yongpeng Ge
    Hanbo Yang
    Xinyue Xiao
    Lin Liang
    Xin Lu
    Guochun Wang
    BMC Pulmonary Medicine, 22
12345